New HIV Treatment Shows Promise in Maintaining Viral Suppression
Gilead has shared new results from its ARTISTRY-1 and ARTISTRY-2 trials, which looked at how well a new combination of […]
Axol Bioscience Expands Eye Research with Newcells Biotech Deal
Axol Bioscience has bought the eye research part of Newcells Biotech. This deal helps Axol offer more types of lab-grown
New Treatment Option for Severe Asthma and Nasal Polyps Approved in Europe
A new medicine called Exdensur (depemokimab) has been approved in Europe for two conditions: severe asthma with type 2 inflammation
Pharmaceutical News
Pharmacist’s Perspective: Latest Updates in the Pharmaceutical World
As a pharmacist, I’d like to share some recent news in the pharmaceutical industry and explain it in simple terms.
Atlanta Company Raises $75 Million to Develop Lung Disease Treatment
An Atlanta-based biotechnology company called Altesa BioSciences recently announced that it has raised $75 million to further develop a drug
Valneva Faces Sales Drop in 2025, Hopes for Turnaround with New Vaccines
Valneva, a company specializing in travel vaccines, saw a decrease in product sales in 2025 due to market restrictions on
Lario Therapeutics Gets $2.4 Million to Develop New Brain Disorder Treatments
Lario Therapeutics, a company based in Edinburgh, has received $2.4 million in new funding from The Michael J Fox Foundation
Pharmaceutical News
New Research Brings Us Closer to Digital Pill Design
A recent study has found that understanding how pills break and how soft or hard they are could help us
Madrigal Pharmaceuticals Expands Treatment Options for Liver Disease MASH
Madrigal Pharmaceuticals, the first company to get U.S. approval for a medicine treating the common liver disease MASH, is now
Big Pharma’s Push for Easier, Faster Cancer Treatments
Big drug companies are working hard to make cancer treatments called CAR-T cell therapies more accessible. These treatments have been